When Less Is More
Despite no big product launches in the US last year, Natco Pharma gained from its strategy of focussing on a few big products. It now hopes to build on this.
by E Kumar Sharma
Feb 14, 2019
2 minutes
VC Nannapaneni, Chairman and Managing Director of Natco Pharma, prefers to stay in the background and lets his son and the Vice Chairman and CEO, Rajeev Nannapaneni, to take charge while he mentors, urging all to singularly focus on product development. He sees no reason to worry thereafter.
This is partly because Rajeev Nannapaneni is not only well regarded within the company for
You’re reading a preview, subscribe to read more.
Start your free 30 days